share_log

Baird Initiates Coverage On Vaxxinity With Outperform Rating, Announces Price Target of $7

Benzinga ·  Sep 8, 2023 04:39

Baird analyst Joel Beatty initiates coverage on Vaxxinity (NASDAQ:VAXX) with a Outperform rating and announces Price Target of $7.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment